全球肽合成市场 – 行业趋势及 2030 年预测

肽合成市场分析和规模   

肽合成是通过按特定顺序组合氨基酸来化学创建肽的过程。它用于药物研究，用于开发新药和研究其相互作用。它能够生产定制设计的肽，用于研究蛋白质结构和功能，以及创建基于肽的疗法和诊断方法。肽合成还有助于高通量筛选和药物发现工作。

Data Bridge Market Research 分析称，2022 年肽合成市场规模为 47 亿美元，到 2030 年将飙升至 88.2 亿美元，预计在预测期内复合年增长率为 8.20%。由于肽在各种疾病状况中的应用日益广泛，“治疗学”在肽合成市场的应用领域中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

肽合成市场范围和细分

Market Definition

Peptide synthesis refers to the chemical process of creating peptides, which are short chains of amino acids linked together by peptide bonds. It involves the stepwise assembly of amino acids in a specific order and often requires the protection of certain functional groups to control the reaction. Peptide synthesis can be achieved through various methods, such as solid-phase synthesis, solution-phase synthesis, or recombinant DNA technology. The goal of peptide synthesis is to produce peptides with precise sequences and desired modifications for various applications, including research, drug development, diagnostics, and therapeutics.

Peptide Synthesis Market Dynamics

Drivers

• Increasing demand for peptide-based therapeutics

Peptides offer unique advantages as therapeutics, such as high specificity, low toxicity, and favorable pharmacokinetic properties. The growing prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is driving the demand for peptide-based drugs. The development of innovative peptide therapeutics and the need for efficient peptide synthesis methods are key drivers for the market.

• Expanding applications in diagnostics and imaging

Peptides play a crucial role in diagnostic applications, including the development of peptide-based biosensors, imaging agents, and biomarker. The rising demand for non-invasive and targeted diagnostic tools, such as peptide-based imaging agents for molecular imaging and peptide-based biosensors for disease detection, is driving the market growth.

Opportunities

• Advancement in therapeutics for rare diseases

Peptides offer potential solutions for treating rare genetic disorders and orphan diseases. The growth of the peptide synthesis market provides an opportunity to develop and manufacture peptide-based therapeutics targeting these conditions. Companies can focus on designing and synthesizing peptides that address specific molecular targets associated with rare diseases, thereby catering to unmet medical needs.

• Personalized medicine and precision therapeutics

Peptides can be tailored to specific patient profiles, leading to the concept of personalized medicine. With advances in genomics, proteomics, and bioinformatics, there is an opportunity for peptide synthesis companies to develop customized peptide therapies that match individual patient characteristics, such as genetic mutations or protein expression patterns. This approach can lead to more effective and targeted treatment strategies.

Restraints/Challenges

• Purification and quality control

Obtaining peptides of high purity is crucial for their successful application in research and therapeutics. Purification methods, such as high-performance liquid chromatography (HPLC), can be time-consuming and require optimization for each peptide sequence. Quality control measures are essential to ensure the accuracy, consistency, and safety of synthesized peptides. Maintaining high-quality standards and efficient purification processes can be a challenge for the peptide synthesis market.

This peptide synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the peptide synthesis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In May 2023, PolyPeptide, a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs), and Numaferm, a German biotech company specialized in process development and production of peptides and proteins, have signed a Preferred Partner Collaboration Agreement for peptide development and production, leveraging PolyPeptide’s cGMP manufacturing capacities, regulatory know-how and market access and Numaferm’s biochemical production platform and expertise in sustainable peptide manufacturing.
• In June 2023, IRBM, an innovative contract research organization, today announced it has signed a new agreement with Merck & Co. Inc., Rahway NJ USA, known as MSD outside the USA and Canada, to continue their collaboration in the peptide therapeutics area.

Global Peptide synthesis Market Scope

The peptide synthesis market is segmented on the basis of type, product, technology, application, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Under 75%
• 75-85%
• Above 85%

Product

• Equipment
• Reagents and Consumables
• Others

Technology

• Solid-Phase Peptide Synthesis (SPPS)
• Solution-Phase Synthesis (SPS)
• Liquid-Phase Peptide Synthesis (LPPS)
• Hybrid and Recombinant

Application

• Therapeutics
• Diagnosis
• Research

End-User

• Pharmaceutical and Biotechnology Companies
• Contract Manufacturing Organization (CMO) or Contract Research Organization (CRO)
• Academic and Research Institutes

Peptide synthesis Market Regional Analysis/Insights

The peptide synthesis market is analysed and market size insights and trends are provided by country, type, product, technology, application, and end user referenced above.

The countries covered in the peptide synthesis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the peptide synthesis market due to the sturdy occurrence of major key players. Furthermore, the rise in the alertness regarding the accessible peptide synthesis technologies and the rising attention on moving the peptide drugs on a commercial scale will further boost the growth of the peptide synthesis market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth of the peptide synthesis market due to the rise in the investments by major key players. Moreover, the increasing consciousness regarding the novel peptide treatments and the growing healthcare expenditure is further anticipated to propel the growth of the peptide synthesis market in the region in the coming years.

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

肽合成市场还为您提供每个国家/地区资本设备医疗保健支出增长、肽合成市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对肽合成市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和肽合成市场份额分析

肽合成市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

肽合成市场的一些主要参与者包括：

• PolyPeptide Group（比利时）
• 默克集团（德国）
• 赛默飞世尔科技（美国）
• Enamine Ltd（乌克兰）
• 阿尔法化学（中国）
• CEM 公司 (美国)
• GenScript (美国)
• AAPPTec（美国）
• Bachem Holding（瑞士）
• AnaSpec, Inc.（美国）
• Biotage（瑞典）
• GYROS PROTEIN TECHNOLOGIES AB（瑞典）
• 先进化学技术（美国）
• 新英格兰肽公司 (美国)
• 贵州信邦药业有限公司 (中国)
• 翰宇药业股份有限公司 (中国)
• USV Private Limited（印度）
• 神隆台湾 (台湾)
• CPC Scientific Inc.（美国）

SKU-47961